Calocurb reviews: six kinds of evidence, one price check
Calocurb reviews sorted by who wrote them and who paid, from a 4.3-star brand widget to a 24-week trial, plus what a 90-capsule bottle costs per day.
Reviews
Calocurb vs Ozempic: one supplement trial vs a drug label
Calocurb is a supplement with one 24-week, 150-person trial (4.3% vs 0.5%). Ozempic is an FDA-approved diabetes drug with a boxed warning. Side by side.
Is Calocurb clinically proven? The C4 trial in numbers
Yes: one 24-week placebo-controlled trial, company-funded. Calocurb lost 4.3% vs 0.5% on placebo, a 3.8-point gap, at the label's maximum dose.
FORMI Weight Loss Complex, reviewed against the SlimBiome trial
Holland and Barrett's new own-label sachet is built on a fibre complex with a real open-access human trial behind it. That trial ran 150 minutes and never weighed anybody.
SlimTide, reviewed: a dozen named ingredients and not one published amount
A July launch release for a probiotic-and-botanical weight-management capsule puts 'Supplement Facts' in its own headline. It names three bacterial strains and nine other ingredients, and attaches a number to none of them.
OxyElite returns with a new panel behind an old name
A famous stimulant brand is back for Europe with a fully disclosed panel. The disclosure is genuinely good; the case published for three of the inclusions is not.
Green tea extract supplements, reviewed with the safety literature attached
A staple of fat-burner formulas, and the one ingredient here where the most important published finding is about harm rather than benefit.
Glucomannan, reviewed against its own authorised claim
One of the few weight-management ingredients with a specific authorised health claim behind it in Europe — and a set of conditions most products quietly fail to meet.